Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
134 tokens/sec
GPT-4o
10 tokens/sec
Gemini 2.5 Pro Pro
47 tokens/sec
o3 Pro
4 tokens/sec
GPT-4.1 Pro
38 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Oxygen, Angiogenesis, Cancer and Immune Interplay in Breast Tumor Micro-Environment: A Computational Investigation (2404.06699v1)

Published 10 Apr 2024 in q-bio.QM

Abstract: Breast cancer is one of the most challenging global health problems among women. This study investigates the intricate breast tumor microenvironment (TME) dynamics utilizing data from Mammary-specific Polyomavirus Middle T Antigen Overexpression mouse models (MMTV-PyMT). It incorporates Endothelial Cells (ECs), oxygen, and Vascular Endothelial Growth Factors (VEGF) to examine the interplay of angiogenesis, hypoxia, VEGF, and the immune cells in cancer progression. We introduce an approach to impute the immune cell fractions within the TME using single-cell RNA-sequencing (scRNA-seq) data from MMTV-PyMT mice. We further quantify our analysis by estimating cell counts using cell size data and laboratory findings from existing literature. Parameter estimation is carried out via a Hybrid Genetic Algorithm (HGA). Our simulations reveal various TME behaviors, emphasizing the critical role of adipocytes, angiogenesis, hypoxia, and oxygen transport in driving immune responses and cancer progression. The global sensitivity analyses highlight potential therapeutic intervention points, such as VEGFs' critical role in EC growth and oxygen transportation and severe hypoxia's effect on the cancer and the total number of cells. The VEGF-mediated production rate of ECs shows an essential time-dependent impact, highlighting the importance of early intervention in slowing cancer progression. These findings align with the observations from the clinical trials demonstrating the efficacy of VEGF inhibitors and suggest a timely intervention for better outcomes.

Summary

We haven't generated a summary for this paper yet.